Coxsackie B virus and its interaction with permissive host cells

Clinical and Diagnostic Virology

Volumn 9, Issue 2-3, 1998, Pages 115-123

  Selinka, Hans Christoph ^a   Huber, Michael ^a   Pasch, Andreas ^a   Klingel, Karin ^a   Aepinus, Christian ^a   Kandolf, Reinhard ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Picornavirus; RasGAP; Tyrosine phosphorylation; Virus persistence; Virus receptors; Virus uptake

Indexed keywords

ARTICLE; COXSACKIE VIRUS B; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; PATHOGENICITY; PERSISTENT VIRUS INFECTION; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HUMANS; INTRACELLULAR FLUID; MEMBRANE PROTEINS; VIRUS LATENCY;

ANIMALIA; COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS B; MURINAE; PICORNAVIRIDAE; RNA VIRUSES;

EID: 0344784396     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(98)00010-5     Document Type: Article

References (39)

1. Bergelson JM, Mohanty JG, Crowell RL, St. John NF, Lublin DM, Finberg RW Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol. 69:1995;1903-1906.
2. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
3. Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis. 175:1997;697-700.
4. Cao Y, Schnurr DP Persistent infection of YAC-1 cells by coxsackievirus B3. J Gen Virol. 69:1988;59-65.
5. Crowell RL, Philipson L Specific alterations of coxsackievirus B3 eluted from HeLa cells. J Virol. 8:1971;509-515.
6. Foulis AK, Farquharson MA, Cameron SO, McGill M, Schönke H, Kandolf R A search for the presence of the enteroviral capsid protein VP1 in pancreas of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia. 33:1990;290-298.
7. Herskowitz A, Wolfgram LJ, Rose NR, Beisel KW Coxsackievirus B3 murine myocarditis-Histopathologic spectrum in genetically defined inbred strains. J Am Coll Cardiol. 9:1987;1311-1319.
8. Huber M, Selinka H-C, Kandolf R Tyrosine phosphorylation events during coxsackievirus B3 replication. J Virol. 71:1997;595-600.
9. Hyöty H, Hiltunen M, Knip M, Laakkonen M, Vähäsalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T, Akerblom HK A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study group. Diabetes. 44:1995;652-657.
10. Jang SK, Davies MV, Kaufman RJ, Wimmer E Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol. 63:1989;1651-1660.
11. Kandolf R, Hofschneider PH Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA. 82:1985;4818-4822.
12. Kandolf R, Canu A, Hofschneider PH Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol. 17:1985;167-181.
13. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA. 84:1987;6272-6276.
14. Kandolf R, Klingel K, Zell R, Selinka H-C, Raab U, Schneider BW, Bultmann B Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology. 35:1993;140-151.
15. Khatib R, Probert A, Reyes MP, Khatib G, Chason JL Mouse strain-related variation as a factor in the pathogenesis of coxsackievirus B3 murine myocarditis. J Gen Virol. 68:1987;2981-2988.
16. Klingel K, Kandolf R The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. Scand J Infect Dis Suppl. 88:1993;79-85.
17. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage and inflammation. Proc Natl Acad Sci USA. 89:1992;314-318.
18. Klingel K, Stephan S, Sauter M, Zell R, McManus B, Bültmann B, Kandolf R Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets. J Virol. 70:1996;8888-8895.
19. Klingel K, Sauter M, Selinka H-C, Bültmann B, Kandolf R The role of CD8+T cells in the pathogenesis of coxsackievirus B3-induced myocarditis. Pathol Res Pract. 193:1997;142.
20. Klump WM, Bergmann I, Müller BC, Ameis D, Kandolf R Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5'uridine residues are regained during RNA synthesis. J Virol. 64:1990;1573-1583.
21. Kramer B, Huber M, Kern C, Klingel K, Kandolf R, Selinka H-C Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions. Virus Res. 48:1997;149-156.
22. Lin K, Abraham KM Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway. Int Immunol. 9:1997;291-306.
23. Lindberg AM, Crowell RL, Zell R, Kandolf R, Petterson U Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 24:1992;187-196.
24. Mapoles JE, Krah DL, Crowell RL Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol. 55:1985;560-566.
25. Matteuci D, Paglianti M, Giangregorio AM, Capobianchi MR, Dianzani F, Bendinelli M Group B coxsackieviruses readily establish persistent infection in human lymphoid cell lines. J Virol. 56:1985;651-654.
26. Modalsli KR, Bukholm G, Mikalsen S-O, Degre M Microinjected coxsackievirus B1 does not replicate in HEp-2 cells. Virology. 185:1991;888-890.
27. Muckelbauer J, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG The structure of coxsackievirus B3 at 3.5 Å resolution. Structure. 3:1995;653-667.
28. Raab de Verdugo U, Selinka H-C, Huber M, Kramer B, Kellermann J, Hofschneider PH, Kandolf R Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol. 69:1995;6751-6757.
29. Rotbart HA, Kinsella JP, Wassermann RL Persistent enterovirus infection in culture-negative meningoencephalitis: demonstration by enzymatic RNA amplification. J Infect Dis. 161:1990;787-791.
30. Schnurr DP, Schmidt NJ Persistent infections. Bendinelli M, Friedman H Coxsackieviruses. A General Update. 1988;181-201 Plenum, New York.
31. Seko Y, Tsuchimochi H, Nakamura T, Okumura K, Naito S, Imataka K, Fujii J, Takaku F, Yazaki Y Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with coxsackievirus B3. Circ Res. 67:1990;360-367.
32. Selinka H-C, Klingel K, Huber M, Kramer B, Kämmerer U, Kandolf R Molecular pathogenesis of myocarditis and cardiomyopathy: Analysis of virus-receptor interactions and tyrosine phosphorylation events. Schultheiss HP, Schwimmbeck P The Role of Immune Mechanisms in Cardiovascular Disease. 1997;17-26 Springer, Berlin.
33. Shafren D, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD Coxsackievirus B1, B3 and B5 use decay accelerating factor as a receptor for cell attachment. J Virol. 69:1995;3873-3877.
34. Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adesion molecule 1 for cell entry. J Virol. 71:1997;4736-4743.
35. Titchener PA, Jenkins O, Szopa TM, Taylor KW, Almond JW Complete nucleotide sequence of a beta-cell tropic variant of coxsackievirus B4. J Med Virol. 42:1994;369-373.
36. Tomko RP, Xu R, Philipson L HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA. 94:1997;3352-3356.
37. Vuorinen T, Vainionpää R, Kettinen H, Hyypiä T Coxsackievirus B3 infection in human leukocytes and lymphoid cell lines. Blood. 84:1994;823-829.
38. Yang D, Wilson JE, Anderson DR, Bohunek L, Cordeiro C, Kandolf R, McManus B In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5′ untranslated region of coxsackievirus B3: Potential targets for antiviral action of antisense oligomers. Virology. 228:1997;63-73.
39. Zell R, Klingel K, Sauter M, Fortmüller U, Kandolf R Coxsackieviral proteins functionally recognize the polioviral cloverleaf structure of the 5′-NTR of a chimeric enterovirus RNA: influence of species-specific host cell factors on virus growth. Virus Res. 39:1995;87-103.